Evidence map›Paper›PMID 28495878›Full record

ArticleScience (New York, N.Y.)2017

Local amplifiers of IL-4Rα-mediated macrophage activation promote repair in lung and liver.

Carlos M Minutti, Lucy H Jackson-Jones, Belén García-Fojeda, Johanna A Knipper, Tara E Sutherland, Nicola Logan, Emma Ringqvist, Raquel Guillamat-Prats, David A Ferenbach, Antonio Artigas and 5 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 1 pooled it
19.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 1 synthesis or guideline pooled it, 195 citations in OpenAlex.

  1. Pooled it
  2. The role of myeloid immune cells in lung epithelial repair.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  3. Article
  4. Article
  5. Single-Cell Insights Into Macrophage Subtypes in Pulmonary Infections.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Article
  7. A Comprehensive Review of the Bovine Immune Response to Pathogens.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Type 2 immunity in allergic diseases.Cellular & molecular immunology · 2025
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Recruited atypical Ly6GScience immunology · 2024
    Article
  19. Article
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 4 countries.

Carlos M MinuttiDepartment of Biochemistry and Molecular Biology I, Complutense University of Madrid, 28040-Madrid, Spain.ORCID 0000-0002-9663-1928
Lucy H Jackson-JonesSchool of Biological Sciences and School of Clinical Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.
Belén García-FojedaDepartment of Biochemistry and Molecular Biology I, Complutense University of Madrid, 28040-Madrid, Spain.ORCID 0000-0002-9558-3020
Johanna A KnipperSchool of Biological Sciences and School of Clinical Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0002-9038-0566
Tara E SutherlandSchool of Biological Sciences and School of Clinical Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0001-9334-8206
Nicola LoganSchool of Biological Sciences and School of Clinical Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0003-4492-673X
Emma RingqvistSchool of Biological Sciences and School of Clinical Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0001-6303-6076
Raquel Guillamat-PratsCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029-Madrid, Spain.ORCID 0000-0001-6960-0985
David A FerenbachSchool of Biological Sciences and School of Clinical Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0002-9202-1428
Antonio ArtigasCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029-Madrid, Spain.ORCID 0000-0002-8029-1017
Cordula StammeDivision of Cellular Pneumology, Research Center Borstel, Leibniz Center for Medicine and Biosciences, 23845 Borstel, and Department of Anesthesiology and Intensive Care, University of Lübeck, 23538 Lübeck, Germany.ORCID 0000-0001-8006-2663
Zissis C ChroneosPulmonary Immunology and Physiology Laboratory, Department of Pediatrics, and Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey PA 17033, USA.ORCID 0000-0002-9841-7917
Dietmar M ZaissSchool of Biological Sciences and School of Clinical Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0003-3596-7062
Cristina CasalsDepartment of Biochemistry and Molecular Biology I, Complutense University of Madrid, 28040-Madrid, Spain.ORCID 0000-0003-2696-0918
Judith E AllenSchool of Biological Sciences and School of Clinical Sciences, University of Edinburgh, Edinburgh EH9 3FL, UK.ORCID 0000-0002-3829-066X
University of Edinburgh · GBUniversidad Complutense de Madrid · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESManchester Academic Health Science Centre · GBPennsylvania State University · USResearch Center Borstel - Leibniz Lung Center · DEWellcome Centre for Cell-Matrix Research · GB

Funding

SP-A Receptor Modulation of Macrophage PhagocytosisR01HL068127 · NHLBI · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI CHRONEOS, ZISSIS C · 2001 to 2004
$883k
Regulation of the lung antiviral inflammatory responseR56HL128746 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHRONEOS, ZISSIS C · 2015 to 2015
$387k
Medical Research Council MR/K01207X/1Medical Research Council MR/K01207X/2Medical Research Council MR/M011755/1NHLBI NIH HHS R01 HL068127NHLBI NIH HHS R56 HL128746Wellcome Trust
6 · The paper itself

Abstract

The type 2 immune response controls helminth infection and maintains tissue homeostasis but can lead to allergy and fibrosis if not adequately regulated. We have discovered local tissue-specific amplifiers of type 2-mediated macrophage activation. In the lung, surfactant protein A (SP-A) enhanced interleukin-4 (IL-4)-dependent macrophage proliferation and activation, accelerating parasite clearance and reducing pulmonary injury after infection with a lung-migrating helminth. In the peritoneal cavity and liver, C1q enhancement of type 2 macrophage activation was required for liver repair after bacterial infection, but resulted in fibrosis after peritoneal dialysis. IL-4 drives production of these structurally related defense collagens, SP-A and C1q, and the expression of their receptor, myosin 18A. These findings reveal the existence within different tissues of an amplification system needed for local type 2 responses.

Indexed as

Macrophage ActivationAnimalsComplement C1qHumansInterleukin-4Listeria monocytogenesListeriosisLiverLungMiceMice, Inbred C57BLNippostrongylusPulmonary Surfactant-Associated Protein AReceptors, Interleukin-4RegenerationStrongylida InfectionsComplement C1qInterleukin-4Pulmonary Surfactant-Associated Protein AReceptors, Interleukin-4

Identifiers

PMID28495878
PMCPMC5737834
OpenAlexW2612351849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.